Sofosbuvir plus velpatasvir treatment for hepatitis C virus in patients with decompensated cirrhosis: a Japanese real-world multicenter study
出版年份 2020 全文链接
标题
Sofosbuvir plus velpatasvir treatment for hepatitis C virus in patients with decompensated cirrhosis: a Japanese real-world multicenter study
作者
关键词
-
出版物
JOURNAL OF GASTROENTEROLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-10-01
DOI
10.1007/s00535-020-01733-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- JSH Guidelines for the Management of Hepatitis C Virus Infection, 2019 Update; Protective Effect of Antiviral Therapy against Hepatocarcinogenesis
- (2020) Yasuhiro Asahina et al. HEPATOLOGY RESEARCH
- Glecaprevir and Pibrentasvir for Japanese patients with chronic hepatitis C genotype 1 or 2 infection: Results from a multicenter, real-world cohort study
- (2019) Eiichi Ogawa et al. HEPATOLOGY RESEARCH
- Real‐world efficacy of elbasvir and grazoprevir for hepatitis C virus (genotype 1): A nationwide, multicenter study by the Japanese Red Cross Hospital Liver Study Group
- (2019) Toshie Mashiba et al. HEPATOLOGY RESEARCH
- Intention‐to‐treat Assessment of Glecaprevir + Pibrentasvir Combination Therapy for Patients with Chronic Hepatitis C in the Real World
- (2019) Akihiro Tamori et al. HEPATOLOGY RESEARCH
- Involvement of portosystemic shunts in impaired improvement of liver function after direct‐acting antiviral therapies in cirrhotic patients with hepatitis C virus
- (2019) Shohei Tsuji et al. HEPATOLOGY RESEARCH
- Real-world virological efficacy and safety of elbasvir and grazoprevir in patients with chronic hepatitis C virus genotype 1 infection in Japan
- (2018) Hidenori Toyoda et al. JOURNAL OF GASTROENTEROLOGY
- Real-world efficacy and safety of ledipasvir and sofosbuvir in patients with hepatitis C virus genotype 1 infection: a nationwide multicenter study by the Japanese Red Cross Liver Study Group
- (2018) Keiji Tsuji et al. JOURNAL OF GASTROENTEROLOGY
- EASL Recommendations on Treatment of Hepatitis C 2018
- (2018) Jean-Michel Pawlotsky et al. JOURNAL OF HEPATOLOGY
- Efficacy and safety of sofosbuvir–velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial
- (2018) Tetsuo Takehara et al. JOURNAL OF GASTROENTEROLOGY
- Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity—LINA cohort)
- (2018) Ivan Gentile et al. Hepatology International
- The presence of varices in patients after hepatitis C eradication predicts deterioration in the FIB‐4 index
- (2018) Yuya Seko et al. HEPATOLOGY RESEARCH
- Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registry
- (2017) Carlos Fernández Carrillo et al. HEPATOLOGY
- Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study
- (2016) Luca Saverio Belli et al. JOURNAL OF HEPATOLOGY
- Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis
- (2016) Graham R. Foster et al. JOURNAL OF HEPATOLOGY
- Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis
- (2016) Michelle C.M. Cheung et al. JOURNAL OF HEPATOLOGY
- Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis
- (2015) Michael P. Curry et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search